Lostam BioPharmaceuticals Overview
- Founded
-
2009

- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Lostam BioPharmaceuticals General Information
Description
Developer of protein therapeutics designed to prevent and treat lethal Gram-negative bacterial infections. The company's protein therapeutics offers a panel of human therapeutic protein candidates and novel pipelines of anti-bacterial drugs capable of combating serious bacterial infections and of withstanding the cunning efforts of bacteria to develop drug-resistant mechanisms, enabling doctors to treat and prevent lethal Gram-negative bacterial infections associated primarily within the hospital setting.
Contact Information
Website
www.lostam-biopharma.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
- Nazareth Industrial Area
- PO Box 2252
- Nazareth 16000
- Israel
Lostam BioPharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | 01-Jul-2017 | Completed | Out of Business | |||
1. Accelerator/Incubator | Completed | Startup |
Lostam BioPharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of protein therapeutics designed to prevent and treat lethal Gram-negative bacterial infections. The company's
Biotechnology
Nazareth, Israel
00000000 00
Lostam BioPharmaceuticals Competitors (8)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Ability Pharma | Venture Capital-Backed | Barcelona, Spain | 00 | 0000 | 000000000000 | 0000 |
000 000000000000 | Venture Capital-Backed | Barcelona, Spain | 00 | 0000 | 00000000000 | 0000 |
000000000 000000 | Venture Capital-Backed | Boston, MA | 00 | 00000 | 0000000000 0 | 00000 |
00000000 | Venture Capital-Backed | Boston, MA | 00 | 0000 | 00000000000 | 0000 |
0000000 | Venture Capital-Backed | Solna, Sweden | 0 | 00.000 | 0000000000 | 00.000 |
Lostam BioPharmaceuticals Patents
Lostam BioPharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20130096282-A1 | Therapeutic antibodies against flagellated pseudomonas aeruginosa | Granted | 01-Mar-2010 | 00000000000 | 0 |
US-8653242-B2 | Therapeutic antibodies against flagellated pseudomonas aeruginosa | Expired - Fee Related | 01-Mar-2010 | 00000000000 | 0 |
EP-2542577-A1 | Improved therapeutic antibodies against flagellated pseudomonas aeruginosa | Withdrawn | 01-Mar-2010 | C07K16/1214 |
Lostam BioPharmaceuticals Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Lewis Neville Ph.D | Founder, Chief Technology Officer & Chief Executive Officer |